Abstract
The use of positive inotropic agents in the acute and chronic treatment of heart failure is associated with a variety of hemodynamic effects. The beneficial effects of these agents, however, are not without associated adverse effects. An increase in cardiac output is achieved through diverse pharmacologic mechanisms of action depending on the specific inotropic agent. Digitalis glycosides, beta-adrenergic agonists, and phosphodiesterase inhibitors are described.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
